ChristineMHayMD

Infectious Disease • Rochester, NY

Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Hay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hay's full profile

Already have an account?

Office
601 Elmwood Ave
Box Med
Rochester, NY 14642
Phone+1 585-275-5871

Fax+1 585-273-1055

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1995 - 1998
Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
Washington University in St. Louis School of MedicineClass of 1992

Certifications & Licensure

NY State Medical License 1999 - 2025
American Board of Internal Medicine Infectious Disease

Clinical Trials

Safety of and Immune Response to a DNA HIV Vaccine (pGA2/JS7) Boosted With a Modified Vaccinia HIV Vaccine (MVA/HIV62) in Healthy Adults Start of enrollment: 2006 Apr 01
Completed
Phase 1
Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults Start of enrollment: 2007 Apr 01
Completed
Phase 1
Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults Start of enrollment: 2012 Apr 01
Completed
Phase 1
Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults Start of enrollment: 2012 May 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

28 citations
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Pl...
Shuying S. Li, Nidhi Kochar, Marnie Elizaga, Christine M. Hay, Gregory J. Wilson
Clinical and Vaccine Immunology. 2017-09-20
37 citations
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV ...
Marnie Elizaga, Shuying S. Li, Nidhi Kochar, Gregory J. Wilson, Mary Allen
Plos One. 2018-09-20
53 citations
Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route ...
Robert W. Frenck, Robert B. Belshe, Rebecca C. Brady, Patricia L. Winokur, James D. Campbell
Vaccine. 2011-08-05

Press Mentions

Should You Wait to Attend Med School?July 23rd, 2024

Grant Support

Study Of Gd-Alum/Mpl HSV-2 Vaccine In Prevention Of Genital Herpes In WomenNational Center For Research Resources2005
ACTG A5143National Center For Research Resources2004
Immune Control Of HIV1 Disease ProgressionNational Institute Of Allergy And Infectious Diseases1999–2000
Immune Control Of HIV1 Disease ProgressionNational Institute Of Allergy And Infectious Diseases1998
HIV CTL In Progressive And Non-Progressive InfectionNational Institute Of Allergy And Infectious Diseases1997